Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.